Bryan M. Wittmann, Ph.D.
Affiliations: | 2004 | Case Western Reserve University School of Medicine, Cleveland, OH, United States |
Area:
Pharmacology, Molecular Biology, OncologyGoogle:
"Bryan Wittmann"Parents
Sign in to add mentor| Monica M. Montano | grad student | 2004 | Case Western Medical School | |
| (Characterization of estrogen down-regulated gene 1 (EDG1) from sequence to function: Role in breast cancer and regulation of estrogen receptor alpha transcriptional activation.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Yeh IJ, Song K, Wittmann BM, et al. (2014) HEXIM1 plays a critical role in the inhibition of the androgen receptor by anti-androgens. The Biochemical Journal. 462: 315-27 |
| Ketchart W, Smith KM, Krupka T, et al. (2013) Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis. Oncogene. 32: 3829-39 |
| Kobayashi S, Stice JP, Kazmin D, et al. (2010) Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer. Molecular Endocrinology (Baltimore, Md.). 24: 2292-302 |
| DuSell CD, Nelson ER, Wittmann BM, et al. (2010) Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators. Molecular Endocrinology (Baltimore, Md.). 24: 33-46 |
| Norris JD, Chang CY, Wittmann BM, et al. (2009) The homeodomain protein HOXB13 regulates the cellular response to androgens. Molecular Cell. 36: 405-16 |
| Joseph JD, Wittmann BM, Dwyer MA, et al. (2009) Inhibition of prostate cancer cell growth by second-site androgen receptor antagonists. Proceedings of the National Academy of Sciences of the United States of America. 106: 12178-83 |
| Frigo DE, Sherk AB, Wittmann BM, et al. (2009) Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro. Molecular Endocrinology (Baltimore, Md.). 23: 1385-96 |
| Wittmann BM, Sherk A, McDonnell DP. (2007) Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators. Cancer Research. 67: 9549-60 |
| Wittmann BM, Fujinaga K, Deng H, et al. (2005) The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1. Oncogene. 24: 5576-88 |
| Montano MM, Bianco NR, Deng H, et al. (2005) Estrogen receptor regulation of quinone reductase in breast cancer: implications for estrogen-induced breast tumor growth and therapeutic uses of tamoxifen. Frontiers in Bioscience : a Journal and Virtual Library. 10: 1440-61 |